Sagittarius Life Science Corp (TPEX:3205)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.80
-0.10 (-0.19%)
At close: Feb 26, 2026
54.63%
Market Cap 3.50B
Revenue (ttm) 424.44M
Net Income (ttm) -46.33M
Shares Out 67.55M
EPS (ttm) -1.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 168,768
Average Volume 198,359
Open 52.40
Previous Close 51.90
Day's Range 51.70 - 52.70
52-Week Range 21.30 - 61.60
Beta 0.77
RSI 59.77
Earnings Date Mar 27, 2026

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 112
Stock Exchange Taipei Exchange
Ticker Symbol 3205
Full Company Profile

Financial Performance

In 2024, Sagittarius Life Science's revenue was 467.75 million, an increase of 6.20% compared to the previous year's 440.46 million. Losses were -48.53 million, -11.82% less than in 2023.

Financial Statements

News

There is no news available yet.